Diagnosis Glaucoma: Recent Episodes
Dr. Kaleem and Dr. Quigley
This is a podcast about glaucoma for patients, family members, or anyone who is interested in learning more about the condition.
In this episode, Dr. Mona Kaleem speaks with Dr. Ethan Lester, a clinical psychologist and Assistant Professor of Psychology in Ophthalmology at Harvard Medical School who works with patients at Mass Eye and Ear navigating chronic eye disease and vision loss. Together, they discuss the bi-directional relationship between chronic eye conditions (such as glaucoma) and mental health and the impact they each have on the other. The discussion also covers the importance and availability of services designed to support mental wellbeing, what those services/sessions look like, and how patients can access them. Please visit www.ethanlesterphd.com to learn more about Dr. Lester’s work.
In this episode, Dr. Mona Kaleem speaks with Dr. Sandra Sieminski, a glaucoma specialist and expert in laser-based glaucoma surgery, who currently serves as Interim Chair of the Department of Ophthalmology at the University at Buffalo’s Ross Eye Institute. Together, they explore cyclophotocoagulation (CPC) and its evolution from traditional transscleral approaches to modern micropulse laser techniques. Their discussion covers the history of CPC, glaucoma types most appropriate for the procedure, potential risks and complications, anesthesia options for the procedure, and essential aspects of post-procedural care. Check out Dr. Sieminski's work at https://medicine.buffalo.edu/faculty/profile.html?ubit=sandrafe
In this episode, Dr. Mona Kaleem interviews Dr. Reena Garg, a glaucoma specialist and clinician-educator in Rockville, Maryland. They discuss the XEN Gel Stent—a newer surgical option—and contrast it with traditional trabeculectomy. The conversation covers differences in candidacy for each procedure, their respective advantages and limitations, and the differences in postoperative recovery.
In this episode, Dr. Harry Quigley interviews Dr. Bryce Chiang, a clinician-scientist at the Wilmer Eye Institute who studies glaucoma pathogenesis and treatment from a biomedical-engineering perspective. They discuss how the biomechanics of the sclera—the eye’s white outer layer—may influence Glaucoma development. They also talk about Dr. Chiang’s ongoing research in drug delivery to the eye, neuro-scleral protection, and the development of treatments that can prevent Glaucoma damage by adjusting ocular biomechanics.
In this episode, Dr. Quigley interviews Dr. Aakriti Garg Shukla, Associate Professor of Ophthalmology at Columbia University Medical Center. They discuss clinical trials investigating the role of nicotinamide (vitamin B3) and pyruvate in preventing retinal damage in glaucoma.
In this episode, Dr. Kaleem interviews Delcora Huggins, a 3rd year medical student conducting research in Ophthalmology. They discuss barriers to glaucoma medication adherence and common problems that patients face while administering eye drops. They also discuss various solutions to address these problems, including optimal drop administering technique and 4 drop aids on the market (AutoDrop, AutoSqueeze, GentleDrop, NanoDropper).
In this episode, Dr. Kaleem interviews Dr. Leon W. Herndon Jr., MD about the importance of family history in the screening and treatment of glaucoma. In the latter half of the episode, they also discuss new initiatives to help improve glaucoma screening.
In this episode, Dr. Quigley interviews Dr. Gary Novack, PhD about the development and FDA approval process of eye drop medications for glaucoma. Towards the end of the podcast, they discuss the following article about recalled eye drops: https://health.ucdavis.edu/news/headlines/fda-recalls-3-brands-of-eye-drops-what-patients-need-to-know-/2023/03
In this episode, Dr. Quigley talks with Dr. David Friedman, MD, PhD, about his research on angle closure glaucoma and how to best treat it. Dr. Friedman is the Alfred and Diane Kaneb Chair in Ophthalmology at Massachusetts Eye and Ear and the Director of the Glaucoma Division at Massachusetts Eye and Ear Institute.
In this episode, Dr. Kaleem talks with Dr. Jennifer Thorne about uveitis (inflammation of the eye) and how it can lead to glaucoma. Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology
In this episode, Dr. Quigley interviews Dr. Osamah Saeedi (Director of the Glaucoma Division and Professor of Ophthalmology at the University of Maryland) about his research on how blood flow affects glaucoma.
In this episode, Dr. Kaleem speaks with Dr. Larry (Lawrence) Geyman about different types of visual changes that patients with glaucoma can experience, such as changes in contrast sensitivity, motion sensitivity, and visual crowding.
In this episode, Dr. Quigley talks with Dr. James Brandt, whose research focuses on childhood-onset glaucoma. Dr. Brandt is Professor of Ophthalmology & Vision Science, Director of the Glaucoma Service and Vice-Chair for International Programs & New Technologies at the University of California, Davis in Sacramento, California.
In this episode, Dr. Kaleem speaks with Dr. Emily Schehlein about an article she co-authored which reviews recent research studies about mindfulness and dietary supplements as complementary treatments for patients with glaucoma. Her article can be found at the following link: https://glaucomatoday.com/articles/2022-mar-apr/novel-treatments-for-the-poor-surgical-candidate?c4src=search:feed
In this episode, Dr. Kaleem talks with Dr. Jampel about how to determine a target intraocular pressure for patients with glaucoma.
In this episode, Dr. Kaleem talks with Beth Glassman about her experience as a patient with glaucoma. They discuss various tips that Beth has found helpful for increasing accessibility in her everyday environment.
In this episode, Dr. Kaleem speaks with Dr. Jella An about glaucoma treatments which are an alternative to daily eye drops. They discuss what these treatments are, how long they last, and who might be a good candidate.
In this episode, Dr. Kaleem speaks with Dr. Anisa Gire about dry eye disease and how it impacts patients with glaucoma.
In this episode, Dr. Kaleem talks with Dr. Jithin Yohannan about what artificial intelligence is and how it could add value to glaucoma care.
In this episode, Dr. Quigley is joined by Dr. Ian Pitha to discuss recent advances in the area of glaucoma surgery research
In this episode, Dr. Quigley and Dr. Ramulu discuss how to manage the challenges with daily activities that can occur for patients with glaucoma.
In this episode, Dr. Quigley talks with Dr. Pradeep Ramulu about the problems that patients with glaucoma can face in completing daily tasks such as driving, reading, and recognizing others.
In this episode, Dr. Elyse McGlumphy talks with Dr. Kaleem about her research using iCare Tonometry, an innovative technology for measuring intraocular pressure at home.
In this episode, Dr. Kaleem and Dr. Quigley discuss what lifestyle habits patients with glaucoma can adopt to complement their regular treatments.
In this episode, Dr. Quigley and Dr. Kaleem discuss what the science says about the usage of medical marijuana for glaucoma.
Happy one year anniversary to Diagnosis Glaucoma and all its listeners! On this anniversary episode, Dr. Quigley and Dr. Kaleem answer a listener question about how eye trauma can lead to glaucoma.
In this episode, Dr. Quigley and Dr. Kaleem discuss the definition of "low vision" and what vision rehabilitation is, as well as when you might consider it. For more information, you can go to: https://www.aao.org/eye-health/diseases/low-vision-aids-rehabilitation.
Dr. Quigley and Dr. Kaleem explain why it is important for glaucoma patients to let their eye doctors know about pregnancies, as well as how glaucoma treatment can be modified during pregnancy. For mothers who would like help with lactation, go to: http://www.sarahquigley.com/.
In this special episode, Dr. Tom Johnson talks with Dr. Kaleem about his research and explains potential stem cell therapies for glaucoma.
While previous episodes have focused on glaucoma in adults, in this episode, Dr. Quigley and Dr. Kaleem discuss how glaucoma manifests in infants and children. They explain its causes, as well as how pediatric glaucoma is diagnosed and treated.
Dr. Quigley and Dr. Kaleem continue to discuss minimally invasive glaucoma surgeries (MIGS) this week, this time focusing the surgeries that go in through the subconjunctival space, specifically the Xen and the PreserFlo, and how they compare to other glaucoma surgery options.
In this third part of the glaucoma surgery series, Dr. Quigley and Dr. Kaleem explain the Minimally Invasive Glaucoma Surgery (MIGS) procedures. They compare these procedures to those discussed in the previous two episodes, Episodes 17 and 18, and outline the risks and benefits to these particular procedures.
Dr. Quigley and Dr. Kaleem continue their discussion of glaucoma surgery options by explaining the tube shunt surgery. They compare it to the trabeculectomy, discussed in Episode 17, and talk about its risks and benefits.
Dr. Quigley and Dr. Kaleem begin their discussion of glaucoma surgical treatment options with the trabeculectomy. They explain what the procedure involves, as well as its risks and benefits.
In this continuation of Episode 15, Dr. Quigley and Dr. Kaleem discuss how glaucoma and cataracts affect each other and surgical options to treat both problems.
In this episode, Dr. Quigley and Dr. Kaleem discuss what cataracts are and the risk factors for developing them. They also explain options for treating cataracts and the risk and benefits of cataract surgery.
Following up on last week's episode, Dr. Quigley and Dr. Kaleem discuss laser treatments for closed angle glaucoma, as opposed to those for open angle glaucoma. They explain what the laser iridotomy is and whether or not patients who are closed angle glaucoma suspects should get it.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this episode, Dr. Quigley and Dr. Kaleem discuss another type of treatment--the laser trabeculoplasty. They explain what it is, how it works, and what to expect as a patient.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In part two of this two episode series, Dr. Quigley and Dr. Kaleem answer many of the most common questions about glaucoma medications, including cost and methods of storing, taking, and remembering to take eye drops.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In part one of this two episode series, Dr. Quigley and Dr. Kaleem describe some of the most commonly used medications to treat glaucoma and ocular hypertension, including their mechanisms and their side effects. Stay tuned for part two!
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this episode, Dr. Quigley and Dr. Kaleem discuss the importance of visual field testing, how often to do it, and directions for how to take it.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
Dr. Quigley and Dr. Kaleem discuss what affects eye pressure, how to measure it, and why it's important in glaucoma.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
The optic nerve is the brain tissue that gets damaged in glaucoma, but there are other conditions that can also affect the optic nerve. In this episode, we'll discuss how we differentiate glaucoma from the other optic nerve diseases which are called "optic neuropathies".
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
This is an extension of episode 6, where we go over details of what it means to have closed angle glaucoma.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
This is an extension of episode 5, where we go over details of what it means to have open angle glaucoma.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this episode, we define the term "angle" as it relates to glaucoma, and explain how you can determine whether you have "open angle" or "closed angle" glaucoma.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this episode, we talk about the signs, symptoms, risk factors, and causes of glaucoma.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this special episode, Dr. Quigley and Dr. Kaleem discuss all the things glaucoma patients should know regarding coronavirus and the eye.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this episode, we'll review all the members of the eye health care team who you may come across during your visit, and we'll go over what to expect when you go in for a glaucoma evaluation.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.
In this first episode of Diagnosis Glaucoma, Dr. Quigley and Dr. Kaleem introduce themselves and the mission of the podcast.
.
.
.
.
.
To support Dr. Mona Kaleem’s and Dr. Harry Quigley’s research please reach out to the Wilmer Eye Institute Development Office:
-For Dr. Mona Kaleem contact:
Daniela Fried
Associate Director of Development
Telephone number: 410-952-4724
Email: dfried2@jhmi.edu
-For Dr. Harry Quigley contact:
Kathy Anglemyer
Senior Associate Director of Development
Telephone number: 443-253-7292
Email: kanglemyer@jhu.edu
To donate online visit: https://www.hopkinsmedicine.org/wilmer/charitable-giving/
Thank you for advancing
glaucoma research! We are so grateful for your support.